beluuga.ai

Overview

Precision Instruments

OLYMPUS CORPORATION

Olympus is a global medical technology company focused on the manufacture and sale of endoscopes and therapeutic devices. Its two core business segments are the Endoscopy Business (gastrointestinal endoscopes, surgical endoscopes, and medical services) and the Therapeutic Devices Business (gastrointestinal treatment instruments, urology, respiratory, energy devices, ENT, and gynecology products). The company leverages its world-leading endoscopy platform and global sales network to serve healthcare professionals and improve patient outcomes worldwide.

Market Cap

¥1,827B

US$11.7B

¥2,091B

US$13.3B

Stock¥1,719▲+2.14%

US$1 = ¥156.80 (2026-10-23)

LTM EV/EBITDA

11.8

LTM EV/EBIT

19.1

LTM PER

23.3

LTM PBR

2.4

Stock vs TOPIX (1Y, base=100)vs TOPIX ▼-32.4%pt

Oct 24, 25 – Oct 23, 26StockTOPIX

1Aug 10, 26Q1 earnings: net profit up 2.1x YoY (¥19.1bn), FY operating profit guidance +40.5% maintained

2Oct 14, 26FDA Warning Letter received (disclosed 10/13) following quality control inspections at 8 sites

MC → EV Bridge

AI Briefing

Generating insights…

Performance & Balance

Revenue 5Y (¥B)

EBITDA 5Y (¥B)

Net Income 5Y (¥B)

Capital Structure

66%

34%

EquityD/E 0.52xDebt

Liquidity vs Debt 5Y (¥B)▼ Net Debt

CashInv. Sec.Debt

Shareholders

Top 10 hold 47.8%

as of 2026-03-31 · Source: Annual Securities Report

The Master Trust Bank of Japan, Ltd. (Trust Account)

19.14%

Custody Bank of Japan, Ltd. (Trust Account)

6.71%

STATE STREET BANK AND TRUST COMPANY 505001 (Standing Proxy: Mizuho Bank, Ltd.)

5.21%

JP MORGAN CHASE BANK 385839 (Standing Proxy: Mizuho Bank, Ltd.)

3.72%

SMBC Trust Bank Ltd. (Retirement Benefit Trust, Sumitomo Mitsui Banking Corporation Account)

3.59%

Morgan Stanley MUFG Securities Co., Ltd.

2.45%

Nippon Life Insurance Company

1.93%

THE CHASE MANHATTAN BANK, N.A. LONDONSECS LENDING OMNIBUS ACCOUNT (Standing Proxy: Mizuho Bank, Ltd.)

1.85%

STATE STREET BANK AND TRUST COMPANY 505103 (Standing Proxy: Mizuho Bank, Ltd.)

1.68%

JP MORGAN CHASE BANK 385642 (Standing Proxy: Mizuho Bank, Ltd.)

1.55%

Management

11 officers

Masato IWASAKI

Outside Director

See "1 a. Status of Directors" above

1958-11-06

Jimmy C. BEASLEY

Outside Director

See "1 a. Status of Directors" above

1963-04-06

Sachiko ICHIKAWA

Outside Director

Apr 1997 Registered as attorney-at-law; joined Tanabe Sogo Law Office Jan 2005 Registered as attorney-at-law in New York State, USA Nov 2009 Auditor, Corporate Officer Development Institute (Public Interest Incorporated Association) Jan 2011 Partner, Tanabe Sogo Law Office (current) Jun 2015 Outside Director, Anritsu Corporation; Director, Corporate Officer Development Institute Apr 2018 Registered as U.S. Certified Public Accountant May 2018 Outside Audit & Supervisory Board Member, Ryohin Keikaku Co., Ltd. Jun 2020 Auditor, Corporate Officer Development Institute Jun 2021 Outside Director, Tokyo Electron Limited; Outside Director, the Company (current) Jun 2022 Director, Corporate Officer Development Institute (current) Jun 2024 Outside Director, Azbil Corporation (current) Significant Concurrent Positions: Partner, Tanabe Sogo Law Office; Director, Corporate Officer Development Institute; Outside Director, Azbil Corporation

1967-01-17

Kohei KAN

Outside Director

See "1 a. Status of Directors" above

1960-03-07

Gary John PRUDEN

Outside Director

See "1 a. Status of Directors" above

1961-05-10

Ruan Marie PENDY

Outside Director

See "1 a. Status of Directors" above

1960-05-08

Hiroshi ISHINO

Outside Director

See "1 a. Status of Directors" above

1951-04-10

Bob WHITE

Representative Director, Representative Executive Officer, President and Chief Executive Officer (CEO)

See "1 a. Status of Directors" above

1962-10-10

David Robert HALE

Outside Director

See "1 a. Status of Directors" above

1984-12-21

Jean-Luc BUTEL

Outside Director

Jan 1998 Corporate Officer, Global Consumer Healthcare, and President, Becton, Dickinson and Company Nov 1999 President, Independence Technology, Johnson & Johnson Aug 2003 President, Asia Pacific Headquarters, Medtronic May 2008 Corporate Officer, Executive Committee Member, Executive Vice President and President, International Group, Medtronic Inc. (now Medtronic plc) Jan 2012 President, International, Baxter International Inc. Jul 2015 Global Healthcare Advisor and President, K8 Global Pte. Ltd. (current) Jun 2016 Outside Director, Takeda Pharmaceutical Company Limited Sep 2017 Outside Director, Novo Holdings A/S Sep 2021 Outside Director, Rani Therapeutics (current) Apr 2022 Outside Director, ICON Group (current) Jun 2026 Outside Director, the Company (scheduled) Significant Concurrent Positions: Global Healthcare Advisor and President, K8 Global Pte. Ltd.; Outside Director, Takeda Pharmaceutical Company Limited; Outside Director, Rani Therapeutics; Outside Director, ICON Group

1956-11-08

Costa SALVUKOS

Outside Director

Jul 2012 Executive Finance Director, Eastern Europe, Middle East and Africa, Merck & Co. Oct 2013 Executive Finance Director, Greater China and Japan, Allergan Asia Limited Sep 2014 Vice President, Finance and Business Development, Asia Pacific, Allergan Asia Limited May 2015 Chief Financial Officer, Europe and Canada Business Unit, Takeda Pharmaceutical Company Limited Apr 2018 Chief Financial Officer, Takeda Pharmaceutical Company Limited Jun 2019 Director, Takeda Pharmaceutical Company Limited Sep 2025 Chairman of the Board, Mitsubishi Tanabe Pharma Corporation (now Tanabe Pharma Corporation) (current) Dec 2025 Independent Outside Director, CSL Limited (current) Jun 2026 Outside Director, the Company (scheduled) Significant Concurrent Positions: Chairman of the Board, Tanabe Pharma Corporation (formerly Mitsubishi Tanabe Pharma Corporation); Independent Outside Director, CSL Limited

1971-04-15

Large Shareholding Reports

Artisan Investments GP LLC

2026-07-07

5.63%

Massachusetts Financial Services Company

2026-03-19

4.94%→3.77%

Baillie Gifford Overseas Limited

2025-09-19

2.90%→2.12%

Amova Asset Management Co., Ltd.

2025-09-19

3.24%→3.37%

Disclosures

No disclosures

Primary Source Filings

TDnet

2026-08-07

Q1 Earnings Flash

FY ending Mar 2027

OLYMPUS CORPORATION

Try the full product

OLYMPUS CORPORATION

Try the full product

More Japanese companies in Precision Instruments